NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia

Cardiovascular Journal of Africa

Volumn 19, Issue 5, 2008, Pages 264-267

  De Greef, Jacques ^a   Funk, Maryke ^a   Vermaak, William J H ^a   Perumal, Nalini S ^b   Libhaber, Carlos D ^b   Vangu, Mboyo Di Tamba ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; EXERCISE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PERFUSION; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 56549113080     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Costello-Boerrigter LC, Burnett JC (jun). The prognostic value of N-terminal proB-type natriuretic peptide. Nat Clin Pract Cardiovasc 2005; 2: 194-201.
2. Anand IS, Fisher LD, Chiang Y, Latini R, Masson S, Maggioni AP, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsaratan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-1283.
3. Schnabel R, Lubos E, Rupprecht H, Espinola-Klein C, Bickel C, Lackner KJ, et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina. J Am Coll Cardiol 2006; 47: 552-558.
4. Pegoraro NR, Naidoo DP, Esterhuizen TM. Prognostic value of N-terminal-pro-brain natriuretic peptide measurement in patients with acute coronary syndromes. Cardiovasc J S Afr 2006; 17: 60-66.
5. Morrow DA, De Lemos JA, Blazing MA, Sabatine MC, Murphy SA, Jarolim P, et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. J Am Med Assoc 2005; 294: 2866-2871.
6. Huang W, Lee M, Perng H, Yang S, Kuo S, Chang H. Circulating brain natriuretic peptide values in healthy men before and after exercise. Metabolism 2002; 51: 1423-1426.
7. Foote RS, Pearlman JD, Siegel AH, Yeo KJ. Detection of exercise-induced ischaemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 2004; 44: 1980-1987.
8. Yeo K, Lee h, Wong K, Foote R. Can exercise-induced changes in Btype natriuretic peptide be used to detect cardiac ischemia? J Card Fail 2005; 11: S59-S64.
9. Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004; 6: 257-260.
10. Hall C. NT-proBNP: The mechanism behind the marker. J Card Fail 2005; 11: S81-S83.
11. Goetze JP. Biochemistry of pro-B-type natriuretic peptides: The endocrine heart revisited. Clin Chem 2004; 50: 1503-1510.
12. De Bruyne B, Bronzwaer JGF, Heyndrickx GR, Paulus WJ. Comparative effects of ischemia and hypoxemia on left ventricular systolic and diastolic function in humans. Circulation 1993; 88: 461-471.
13. Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, et al. Direct comparison of B-type natriuretic peptide (BNP) and aminoterminal proBNP in a large population of patients with chronic and symptomatic heart failure: The Valsartan Heart Failure (Val-HeFT) data. Clin Chem 2006; 52: 1528-1538.
14. Hammerer-Lercher A, Neubauer E, Muller S, Pachinge O, Puschendorf B, Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001; 310: 193-197.
15. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta 2004; 341: 41-48.
16. Richards M, Nicholls G, Espiner EA, Lainchbury JG, Troughton RW, Elliot J, et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 2006; 47: 52-60.
17. Pfister R, Schneider CA. Natriuretic peptides BNP and NT- pro-BNP: established laboratory markers in clinical practice or just perspectives? Clin Chim Acta 2004; 349: 25-38.
18. Luchner A, Hengstenberg C, Lowel H, Riegger GAJ, Schunkert H, Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 2005; 46: 118-123.
19. Underwood SR, Anostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: The evidence. Eur J Nuclear Med Molec Imag 2004; 31: 261-291.
20. Froelicher VF, Lehmann KG, Thomas R, Goldman S, Morrison D, Edson R, et al. The electrocardiographic exercise test in a population with reduced workup bias: diagnostic performance, computerized interpretation, and multivariable prediction. Veterans Affairs Cooperative Study in Health Services #016 (QUEXTA) study group. Quantitative exercise testing and angiography. Ann Intern Med 1998; 128: 965-974.
21. Sandler MP, Coleman RE, Patton JA, et al. Diagnostic Nuclear Medicine, 4th ed, Philadelphia: Lippincott Williams & Wilkins, 2003.
22. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44: 1988-1995.
23. Staub D, Jonas N, Zellweger MJ, Nusbaumer C, Wild D, Pfisterer ME, et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med 2005; 118: e9-e16.
24. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Muller KD, et al. Nterminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 2004; 148: 612-620.
25. Wolber T, Maeder M, Weilenmann D, Duru F, Bluzaite I, Riesen W, et al. Integration of B-type natriuretic levels with clinical data and exercise testing for predicting coronary artery disease. Am J Cardiol 2006; 98: 764-767.
26. Apple FS, Panteghini M, Ravkilde J, Mair J, Wu AHB, Tate J, et al. Quality specification for B-type natriuretic peptide assays. Clin Chem 2005; 51: 486-493.
27. Win HK, Chang S, Raizner M, Shah G, Al Basky F, Desai U, et al. Percent change in B-type natriuretic levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia. Am Heart J 2005; 150: 695-700.
28. Palumbo B, Siepi D, Lupatelli G, Sinzinger H, Fiorucci G, Annibletti PF, et al. Usefulness of brain natriuretic peptide levels to discriminate patients with stable angina pectoris without and with electrocardiographic myocardial ischemia and patients with healed myocardial infarction. Am J Cardiol 2004; 94: 780-783.
29. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease. Circulation 2003; 108: 2987-2992.
30. Bergeron S, Moller E, Baily KR, Chen HH, Burnett JC, Pellika PA. Exertional changes in circulating cardiac natriuretic peptides in patients with suggested coronary artery disease. J Am Soc Echocardiogr 2006; 19: 772-776.
31. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain Natriuretic peptides during acute myocardial ischemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond) 1995; 88: 551-556.
32. Zaid Gh, Tanchilevitch A, Rivlin E, Gropper R, Rosenschein U, Lanir A, Goldhammer E. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with Spect perfusion imaging. Int J Cardiol 2007; 117: 157-164.
33. Staub D, Nusbaumer C, Zellweger MJ, Jonas N, Wild D, Pfisterer ME, et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 2006; 151: 1223-1230.
34. Suttner SW, Boldt J. Natriuretic peptide system: Physiology and clinical utility. Curr Opin Crit Care 2004; 10: 336-341.
35. Salinas G, Daher IN, Okorodudu AO, Ahmad M. B-type natriuretic peptide is not a marker of ischemia during dobutamine stress echocardiography. J Am Soc Echocardiogr 2007; 20: 23-26.
36. Asada J, Tsuji H, Iwasaka T, Thomas J, Lauer MS. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia. Am J Cardiol 2004; 93: 702-704.
37. Karabinos I, Karvouni E, Chiotinis N, Papadopoulos A, Simeonidis P, Tsolas O, Katritsis D. Acute changes in N-terminal pro-brain natriuretic peptide induced by dobutamine stress echocardiography. Eur J Echocardiogr 2007; 4: 265-274.